首页> 美国卫生研究院文献>International Journal of Molecular Medicine >Treatment of type 2 diabetes mellitus via reversing insulin resistance and regulating lipid homeostasis in vitro and in vivo using cajanonic acid A
【2h】

Treatment of type 2 diabetes mellitus via reversing insulin resistance and regulating lipid homeostasis in vitro and in vivo using cajanonic acid A

机译:使用马来酸A通过体内外逆转胰岛素抵抗和调节脂质稳态来治疗2型糖尿病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study investigated the effects of cajanonic acid A (CAA), extracted from the leaves of Cajanus cajan (L.) Millsp with a purity of 98.22%, on the regulatory mechanisms of glucose and lipid metabolism. HepG2 cells transfected with a protein-tyrosine phosphatase 1B (PTP1B) overexpression plasmid were established. The cells, induced with insulin resistance by dexamethasone (Dex) treatment, together with type 2 diabetes mellitus (T2DM) model rats and ob/ob mice, were used in the present study. The effects of CAA treatment on the differentiation of 3T3-L1 adipocytes were determined using Oil Red O. The expression levels of insulin signaling factors were detected via reverse transcription-quantitative polymerase chain reaction and western blot analyses. The results revealed that the overexpression of PTP1B contributed to insulin resistance, which was reversed by CAA treatment via inhibiting the activity of PTP1B and by regulating the expression of associated insulin signaling factors. The treatment of cell lines with Dex led to increased expression of PTP1B but decreased glucose consumption, and decreased tyrosine phosphorylation of insulin receptor, insulin receptor substrate 1, and phosphoinositide 3-kinase. Treatment with CAA not only reduced the fasting blood glucose levels and protected organs from damage, but also reduced the serum fasting levels of total cholesterol, triglycerides and low-density lipoprotein cholesterol in the T2DM rats. CAA treatment also inhibited adipocyte differentiation and decreased the mRNA levels of various adipogenic genes. Furthermore, CAA treatment restored the transduction of insulin signaling by regulating the expression of PTP1B and associated insulin signaling factors. Treatment with CAA also reduced the problems associated with hyperglycemia and hyperlipidemia. In conclusion, CAA may be used to cure T2DM via restoring insulin resistance and preventing obesity.
机译:本研究调查了以纯度为98.22%的卡赞纳斯·卡扬(L.)Millsp叶片提取的卡扬酸A(CAA)对葡萄糖和脂质代谢的调控机制的影响。建立了用蛋白酪氨酸磷酸酶1B(PTP1B)过表达质粒转染的HepG2细胞。本研究使用地塞米松(Dex)处理诱导的胰岛素抵抗细胞,以及2型糖尿病(T2DM)模型大鼠和ob / ob小鼠。用油红O测定CAA处理对3T3-L1脂肪细胞分化的影响。通过逆转录-定量聚合酶链反应和蛋白质印迹分析检测胰岛素信号因子的表达水平。结果表明,PTP1B的过表达促进了胰岛素抵抗,CAA处理通过抑制PTP1B的活性和调节相关胰岛素信号转导因子的表达来逆转胰岛素抵抗。用Dex处理细胞系导致PTP1B表达增加,但减少了葡萄糖消耗,并降低了胰岛素受体,胰岛素受体底物1和磷酸肌醇3-激酶的酪氨酸磷酸化。 CAA处理不仅降低了空腹血糖水平,保护了器官免受损害,还降低了T2DM大鼠的总胆固醇,甘油三酸酯和低密度脂蛋白胆固醇的血清空腹水平。 CAA处理还抑制了脂肪细胞的分化并降低了各种脂肪形成基因的mRNA水平。此外,CAA治疗通过调节PTP1B和相关胰岛素信号转导因子的表达恢复了胰岛素信号转导。用CAA治疗还减少了与高血糖和高血脂有关的问题。总之,CAA可用于通过恢复胰岛素抵抗和预防肥胖来治愈T2DM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号